Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 326267, 11 pages
http://dx.doi.org/10.1155/2013/326267
Research Article

Phosphocitrate Is Potentially a Disease-Modifying Drug for Noncrystal-Associated Osteoarthritis

1Department of Orthopedic Surgery, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA
2Department of Biostatistics, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA

Received 18 December 2012; Accepted 10 January 2013

Academic Editor: Andre Van Wijnen

Copyright © 2013 Yubo Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Müller-Ladner, J. Kriegsmann, J. Tschopp, R. E. Gay, and S. Gay, “Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis,” Arthritis & Rheumatism, vol. 38, no. 4, pp. 477–484, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. T. Konttinen, T. F. Li, J. Mandelin et al., “Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium,” Arthritis & Rheumatism, vol. 43, pp. 275–280, 2000. View at Google Scholar
  3. W. K. Aicher, A. H. Heer, A. Trabandt et al., “Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients,” Journal of Immunology, vol. 152, no. 12, pp. 5940–5948, 1994. View at Google Scholar · View at Scopus
  4. N. Cagnard, F. Letourneur, A. Essabbani et al., “Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes,” European Cytokine Network, vol. 16, no. 4, pp. 289–292, 2005. View at Google Scholar · View at Scopus
  5. M. D. Smith, S. Triantafillou, A. Parker, P. P. Youssef, and M. Coleman, “Synovial membrane inflammation and cytokine production in patients with early osteoarthritis,” The Journal of Rheumatology, vol. 24, no. 2, pp. 365–371, 1997. View at Google Scholar · View at Scopus
  6. M. J. Benito, D. J. Veale, O. FitzGerald, W. B. van den Berg, and B. Bresnihan, “Synovial tissue inflammation in early and late osteoarthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1263–1267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kato, A. Matsumine, T. Wakabayashi et al., “Large-scale gene expression profiles, differentially represented in osteoarthritic synovium of the knee joint using cDNA microarray technology,” Biomarkers, vol. 12, no. 4, pp. 384–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Sun, D. R. Mauerhan, G. S. Firestein, B. J. Loeffler, E. N. Hanley, and H. E. Gruber, “Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile,” The Journal of Rheumatology, vol. 36, no. 1, pp. 141–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. B. Hamilton, “Diseases associated with CPPD deposition disease,” Arthritis & Rheumatism, vol. 19, supplement 3, pp. 353–357, 1976. View at Google Scholar · View at Scopus
  10. G. J. Carroll, R. A. Stuart, J. A. Armstrong, P. D. Breidahl, and B. A. Laing, “Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1β,” The Journal of Rheumatology, vol. 18, no. 6, pp. 861–866, 1991. View at Google Scholar · View at Scopus
  11. B. A. Derfus, J. B. Kurian, J. J. Butler et al., “The high prevalence of pathologic calcium crystals in pre-operative knees,” The Journal of Rheumatology, vol. 29, no. 3, pp. 570–574, 2002. View at Google Scholar · View at Scopus
  12. S. Nalbant, J. A. M. Martinez, T. Kitumnuaypong, G. Clayburne, M. Sieck, and H. R. Schumacher Jr., “Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies,” Osteoarthritis and Cartilage, vol. 11, no. 1, pp. 50–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fuerst, L. Lammers, F. Schäfer et al., “Investigation of calcium crystals in OA knees,” Rheumatology International, vol. 30, no. 5, pp. 623–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sun, D. R. Mauerhan, P. R. Honeycutt et al., “Calcium deposition in osteoarthritic meniscus and meniscal cell culture,” Arthritis Research and Therapy, vol. 12, no. 2, article R56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. H. S. Cheung, “Biologic effects of calcium-containing crystals,” Current Opinion in Rheumatology, vol. 17, pp. 336–340, 2005. View at Google Scholar
  16. Y. Sun, L. Wenger, C. E. Brinckerhoff, R. R. Misra, and H. S. Cheung, “Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway: involvement of transcription factor binding sites AP-1 and PEA-3,” The Journal of Biological Chemistry, vol. 277, no. 2, pp. 1544–1552, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. Morgan, L. C. Whelan, J. D. Sallis, C. J. McCarthy, D. J. Fitzgerald, and G. M. McCarthy, “Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta,” Arthritis & Rheumatism, vol. 50, no. 5, pp. 1642–1649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Sun, X. R. Zeng, L. Wenger, and H. S. Cheung, “Basic calcium phosphate crystals stimulate the endocytotic activity of cells—inhibition by anti-calcification agents,” Biochemical and Biophysical Research Communications, vol. 312, no. 4, pp. 1053–1059, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Fuerst, J. Bertrand, L. Lammers et al., “Calcification of articular cartilage in human osteoarthritis,” Arthritis & Rheumatism, vol. 60, no. 9, pp. 2694–2703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Habata, H. Ohgushi, Y. Takakura et al., “Relationship between meniscal degeneration and element contents,” Biological Trace Element Research, vol. 79, no. 3, pp. 247–256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. P. H. Pritzker, “Counterpoint: hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis,” Current Rheumatology Reports, vol. 11, no. 2, pp. 148–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. P. Tew, C. Mahle, J. Benavides, J. E. Howard, and A. L. Lehninger, “Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth,” Biochemistry, vol. 19, no. 9, pp. 1983–1988, 1980. View at Google Scholar · View at Scopus
  23. D. Nair, R. P. Misra, J. D. Sallis, and H. S. Cheung, “Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18920–18925, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. H. S. Cheung, J. D. Sallis, and J. A. Struve, “Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystal-induction of metalloproteinase synthesis by phosphocitrate,” Biochimica et Biophysica Acta, vol. 1315, no. 2, pp. 105–111, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Sun, P. Reuben, L. Wenger, J. D. Sallis, K. D. Demadis, and H. S. Cheung, “Inhibition of calcium phosphate-DNA coprecipitates induced cell death by phosphocitrates,” Frontiers in Bioscience, vol. 10, pp. 803–808, 2005. View at Google Scholar · View at Scopus
  26. H. S. Cheung, J. D. Sallis, K. D. Demadis, and A. Wierzbicki, “Phosphocitrate blocks calcification-induced articular joint degeneration in a guinea pig model,” Arthritis & Rheumatism, vol. 54, no. 8, pp. 2452–2461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. H. S. Cheung, “Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease,” Current Opinion in Rheumatology, vol. 12, no. 3, pp. 223–227, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ding, C. C. Danielsen, and I. Hvid, “The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis,” Calcified Tissue International, vol. 82, no. 1, pp. 77–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. C. Ward, R. Shankar, and J. D. Sallis, “A possible antiatherogenic role for phosphocitrate through modulation of low density lipoprotein uptake and degradation in aortic smooth muscle cells,” Atherosclerosis, vol. 65, no. 1-2, pp. 117–124, 1987. View at Google Scholar · View at Scopus
  30. H. E. Krug, “Fibroblasts from mice with progessive ankylosis proliferate excessively in response to transforming growth factor-beta 1,” Journal of Investigative Medicine, vol. 46, no. 4, pp. 134–139, 1998. View at Google Scholar · View at Scopus
  31. P. A. Turhanen, K. D. Demadis, S. Peräniemi, and J. J. Vepsäläinen, “A novel strategy for the preparation of naturally occurring phosphocitrate and its partially esterified derivatives,” Journal of Organic Chemistry, vol. 72, no. 4, pp. 1468–1471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Pfaffl, H. H. D. Meyer, and H. Sauerwein, “Quantification of insulin-like growth factor-1 (IGF-1) mRNA: development and validation of an internally standardised competitive reverse transcription-polymerase chain reaction,” Experimental and Clinical Endocrinology and Diabetes, vol. 106, no. 6, pp. 506–513, 1998. View at Google Scholar · View at Scopus
  33. H. S. Cheung, “Phosphocitrate as a potential therapeutic strategy for crystal deposition disease,” Current Rheumatology Reports, vol. 3, no. 1, pp. 24–28, 2001. View at Google Scholar · View at Scopus
  34. M. M. Cooke, G. M. McCarthy, J. D. Sallis, and M. P. Morgan, “Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1β and cyclooxygenase-2 mRNA in human breast cancer cell lines,” Breast Cancer Research and Treatment, vol. 79, no. 2, pp. 253–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. C. L. Hill, D. J. Hunter, J. Niu et al., “Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 12, pp. 1599–1603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. F. W. Roemer, Y. Zhang, J. Niu et al., “Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study,” Radiology, vol. 252, no. 3, pp. 772–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. D. A. Walsh, C. S. Bonnet, E. L. Turner, D. Wilson, M. Situ, and D. F. McWilliams, “Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis,” Osteoarthritis and Cartilage, vol. 15, no. 7, pp. 743–751, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Del Rey, E. Izquierdo, S. Caja et al., “Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1α/vascular endothelial growth factor-mediated pathway in immunodeficient mice,” Arthritis & Rheumatism, vol. 60, no. 10, pp. 2926–2934, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. COX-2 Inhibitors, “New medication for arthritis pain,” Mayo Clinic Health Letter, vol. 17, article 7, 1999. View at Google Scholar
  40. N. E. Lane, “Pain management in osteoarthritis: the role of COX-2 inhibitors,” Journal of Rheumatology Supplement, vol. 24, no. 49, pp. 20–24, 1997. View at Google Scholar · View at Scopus
  41. G. Saxler, F. Löer, M. von Knoch, F. von Knoch, and U. Hanesch, “Localization of the neurokinin1 receptor in hip joints of patients with painful osteoarthritis,” Zeitschrift fur Orthopadie und Ihre Grenzgebiete, vol. 143, no. 4, pp. 424–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Yamaguchi, T. Kugimiya, and T. Miyazaki, “Substance P receptor in U373 MG human astrocytoma cells activates mitogen-activated protein kinases ERK1/2 through Src,” Brain Tumor Pathology, vol. 22, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. T. M. O'Connor, J. O'Connell, D. I. O'Brien, T. Goode, C. P. Bredin, and F. Shanahan, “The role of substance P in inflammatory disease,” Journal of Cellular Physiology, vol. 201, no. 2, pp. 167–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. R. E. Miller, P. B. Tran, R. Das et al., “CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. 20602–20607, 2012. View at Google Scholar
  45. N. Busso, V. Péclat, A. So, and A. P. Sappino, “Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints,” Annals of the Rheumatic Diseases, vol. 56, no. 9, pp. 550–557, 1997. View at Google Scholar · View at Scopus
  46. O. Slot, N. Brünner, H. Locht, P. Oxholm, and R. W. Stephens, “Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 58, no. 8, pp. 488–492, 1999. View at Google Scholar · View at Scopus
  47. W. Schwab, J. M. Gavlik, T. Beichler et al., “Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and β1-integrin,” Histochemistry and Cell Biology, vol. 115, no. 4, pp. 317–323, 2001. View at Google Scholar · View at Scopus
  48. A. Trabandt, W. K. Aicher, R. E. Gay, V. P. Sukhatme, H. G. Fassbender, and S. Gay, “Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibrolasts,” Rheumatology International, vol. 12, no. 2, pp. 53–59, 1992. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Sun, L. Wenger, C. E. Brinckerhoff, R. R. Misra, and H. S. Cheung, “Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway: involvement of transcription factor binding sites AP-1 and PEA-3,” The Journal of Biological Chemistry, vol. 277, no. 2, pp. 1544–1552, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Kawasaki, K. Komai, M. Nakamura et al., “Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis,” Oncogene, vol. 22, no. 44, pp. 6839–6844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Okabe, Y. Ohmori, A. Tanigami et al., “Detection of gene expression in synovium of patients with osteoarthritis using a random sequencing method,” Acta Orthopaedica, vol. 78, no. 5, pp. 687–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. W. H. Busby Jr., S. A. Yocum, M. Rowland et al., “Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid,” Osteoarthritis and Cartilage, vol. 17, no. 4, pp. 547–555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. D. R. Clemmons, W. H. Busby Jr., A. Garmong et al., “Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 694–703, 2002. View at Publisher · View at Google Scholar · View at Scopus